Psychosomatics最新文献

英文中文

Design and Implementation of a Regional Inpatient Psychiatry Unit for Patients who are Positive for Asymptomatic SARS-CoV-2 区域无症状SARS-CoV-2阳性患者住院精神科病房的设计与实施

IF 3.4 Q2 Medicine

Psychosomatics

Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.06.018

Andrew F. Angelino M.D. , Constantine G. Lyketsos M.D. , M. Shafeeq Ahmed M.D. , James B. Potash M.D. , Bernadette A. Cullen M.B., B.Ch., B.A.O.

Background

Patients with psychiatric illnesses are particularly vulnerable to highly contagious, droplet-spread organisms such as SARS-CoV-2. Patients with mental illnesses may not be able to consistently follow up behavioral prescriptions to avoid contagion, and they are frequently found in settings with close contact and inadequate infection control, such as group homes, homeless shelters, residential rehabilitation centers, and correctional facilities. Furthermore, inpatient psychiatry settings are generally designed as communal spaces, with heavy emphasis on group and milieu therapies. As such, inpatient psychiatry services are vulnerable to rampant spread of contagion.

Objective

With this in mind, the authors outline the decision process and ultimate design and implementation of a regional inpatient psychiatry unit for patients infected with asymptomatic SARS-CoV-2 and share key points for consideration in implementing future units elsewhere.

Conclusion

A major takeaway point of the analysis is the particular expertise of trained experts in psychosomatic medicine for treating patients infected with SARS-CoV-2.

精神疾病患者特别容易感染高度传染性的飞沫传播生物，如SARS-CoV-2。精神疾病患者可能无法始终如一地遵循行为处方以避免传染，并且他们经常在密切接触和感染控制不足的环境中被发现，例如集体之家、无家可归者收容所、住宅康复中心和惩教设施。此外，住院精神病学设置通常被设计为公共空间，重点强调群体和环境治疗。因此，住院精神病学服务很容易受到传染病猖獗传播的影响。基于此，作者概述了无症状SARS-CoV-2患者区域住院精神病学单位的决策过程和最终设计与实施，并分享未来在其他地方实施单位时应考虑的要点。结论经培训的心身医学专家在治疗SARS-CoV-2患者方面具有特殊的专业知识，是本分析的主要收获点。

{"title":"Design and Implementation of a Regional Inpatient Psychiatry Unit for Patients who are Positive for Asymptomatic SARS-CoV-2","authors":"Andrew F. Angelino M.D. , Constantine G. Lyketsos M.D. , M. Shafeeq Ahmed M.D. , James B. Potash M.D. , Bernadette A. Cullen M.B., B.Ch., B.A.O.","doi":"10.1016/j.psym.2020.06.018","DOIUrl":"10.1016/j.psym.2020.06.018","url":null,"abstract":"<div><h3>Background</h3><p>Patients with psychiatric illnesses are particularly vulnerable to highly contagious, droplet-spread organisms such as SARS-CoV-2. Patients with mental illnesses may not be able to consistently follow up behavioral prescriptions to avoid contagion, and they are frequently found in settings with close contact and inadequate infection control, such as group homes, homeless shelters, residential rehabilitation centers, and correctional facilities. Furthermore, inpatient psychiatry settings are generally designed as communal spaces, with heavy emphasis on group and milieu therapies. As such, inpatient psychiatry services are vulnerable to rampant spread of contagion.</p></div><div><h3>Objective</h3><p>With this in mind, the authors outline the decision process and ultimate design and implementation of a regional inpatient psychiatry unit for patients infected with asymptomatic SARS-CoV-2 and share key points for consideration in implementing future units elsewhere.</p></div><div><h3>Conclusion</h3><p>A major takeaway point of the analysis is the particular expertise of trained experts in psychosomatic medicine for treating patients infected with SARS-CoV-2.</p></div>","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 662-671"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.06.018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38277958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

An Intravenous Lorazepam Infusion for Dissociative Amnesia: A Case Report 劳拉西泮静脉输注治疗游离性遗忘1例

IF 3.4 Q2 Medicine

Psychosomatics

Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.01.009

Shixie Jiang M.D. , Steven Gunther M.D. , Kimberly Hartney M.D. , Theodore A. Stern M.D.

引用次数: 0

Can Memantine Improve Catatonia and Co-occurring Cognitive Dysfunction? A Case Report and Brief Literature Review 美金刚能改善紧张症和并发的认知功能障碍吗?1例报告及简要文献回顾

IF 3.4 Q2 Medicine

Psychosomatics

Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.05.026

Julie Graziane M.D., Erin Davidowicz M.D., Andrew Francis Ph.D., M.D.

引用次数: 2

The Feasibility and Impact of a Suicide Risk Screening Program in Rural Adult Primary Care: A Pilot Test of the Ask Suicide-Screening Questions Toolkit 农村成人初级保健自杀风险筛查项目的可行性和影响:自杀筛查问题询问工具包的试点测试

IF 3.4 Q2 Medicine

Psychosomatics

Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.05.002

Mary A. LeCloux Ph.D. , Mathew Weimer M.D. , Stacey L. Culp Ph.D. , Karissa Bjorkgren B.S. , Samantha Service M.S. , John V. Campo M.D.

Objective

The purpose of this study was to evaluate the feasibility and impact of a suicide risk screening program in a rural West Virginia primary care practice.

Methods

Patients presenting for routine and sick visits were asked to participate in electronic suicide risk screening using the Ask Suicide-Screening Questions tool; screen positive individuals were assessed with the Ask Suicide-Screening Questions Brief Suicide Safety Assessment. Screening program feasibility was evaluated by the proportion of patients consenting to participate, participant Ask Suicide-Screening Questions and Brief Suicide Safety Assessment completion rates, and response to a question asking whether primary care providers should ask about suicide. Screening impact was evaluated quasi-experimentally by comparing electronic medical record documentation of suicide risk screening, assessment, and risk determination in practice patients before and after implementing the screening program.

Results

Over half of the patients approached agreed to participate in a research study about suicide (N = 196; 57.7%). Feasibility of the screening program was demonstrated by the high completion rates for the Ask Suicide-Screening Questions (99.0%) and the Brief Suicide Safety Assessment (100.0%) among study participants. Additionally, 95.4% (N = 187) of participants agreed primary care providers should screen patients for suicide. Suicide screening rates rose significantly between the baseline and intervention phases (5.8% to 61.0%; X² = 200.61, P < 0.001), as did suicide risk detection rates (0.7% to 6.2%; X² = 12.58, P < 0.001).

Conclusion

Suicide risk screening was feasible and well accepted by adult patients in rural primary care and has potential to improve suicide risk detection in this setting.

目的本研究的目的是评估自杀风险筛查项目在西弗吉尼亚州农村初级保健实践中的可行性和影响。方法采用“询问自杀筛查问题”(Ask suicide screening Questions)工具，要求就诊的患者参与电子自杀风险筛查;对筛查阳性个体进行自杀筛查问题简要自杀安全评估。筛选方案的可行性通过同意参与的患者比例、参与者询问自杀筛选问题和简要自杀安全评估完成率以及对初级保健提供者是否应该询问自杀问题的回答来评估。通过比较实施筛查计划前后患者自杀风险筛查、评估和风险确定的电子病历文件，对筛查的影响进行准实验评估。结果超过一半的患者同意参加一项关于自杀的研究(N = 196;57.7%)。筛选方案的可行性通过研究参与者自杀筛选问题的高完成率(99.0%)和简要自杀安全评估(100.0%)得到证明。此外，95.4% (N = 187)的参与者同意初级保健提供者应该对患者进行自杀筛查。自杀筛查率在基线和干预阶段之间显著上升(5.8%至61.0%;X2 = 200.61, P <0.001)，自杀风险检出率也是如此(0.7%至6.2%;X2 = 12.58, P <0.001)。结论自杀风险筛查在农村初级保健成人患者中是可行的，且被广泛接受，具有提高自杀风险检测水平的潜力。

{"title":"The Feasibility and Impact of a Suicide Risk Screening Program in Rural Adult Primary Care: A Pilot Test of the Ask Suicide-Screening Questions Toolkit","authors":"Mary A. LeCloux Ph.D. , Mathew Weimer M.D. , Stacey L. Culp Ph.D. , Karissa Bjorkgren B.S. , Samantha Service M.S. , John V. Campo M.D.","doi":"10.1016/j.psym.2020.05.002","DOIUrl":"10.1016/j.psym.2020.05.002","url":null,"abstract":"<div><h3>Objective</h3><p>The purpose of this study was to evaluate the feasibility and impact of a suicide risk screening program in a rural West Virginia primary care practice.</p></div><div><h3>Methods</h3><p>Patients presenting for routine and sick visits were asked to participate in electronic suicide risk screening using the Ask Suicide-Screening Questions tool; screen positive individuals were assessed with the Ask Suicide-Screening Questions Brief Suicide Safety Assessment. Screening program feasibility was evaluated by the proportion of patients consenting to participate, participant Ask Suicide-Screening Questions and Brief Suicide Safety Assessment completion rates, and response to a question asking whether primary care providers should ask about suicide. Screening impact was evaluated quasi-experimentally by comparing electronic medical record documentation of suicide risk screening, assessment, and risk determination in practice patients before and after implementing the screening program.</p></div><div><h3>Results</h3><p>Over half of the patients approached agreed to participate in a research study about suicide (<em>N</em> = 196; 57.7%). Feasibility of the screening program was demonstrated by the high completion rates for the Ask Suicide-Screening Questions (99.0%) and the Brief Suicide Safety Assessment (100.0%) among study participants. Additionally, 95.4% (<em>N</em> = 187) of participants agreed primary care providers should screen patients for suicide. Suicide screening rates rose significantly between the baseline and intervention phases (5.8% to 61.0%; X<sup>2</sup> = 200.61, <em>P</em> < 0.001), as did suicide risk detection rates (0.7% to 6.2%; X<sup>2</sup> = 12.58, <em>P</em> < 0.001).</p></div><div><h3>Conclusion</h3><p>Suicide risk screening was feasible and well accepted by adult patients in rural primary care and has potential to improve suicide risk detection in this setting.</p></div>","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 698-706"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.05.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38143657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 11

Challenges of Electronic Medication Entry—Working Toward Reconciliation: A Case-Based Discussion 电子药物入门的挑战-迈向和解:基于个案的讨论

IF 3.4 Q2 Medicine

Psychosomatics

Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.02.001

Tamar C. Katz M.D., Ph.D. , Janet Wozniak M.D. , Oliver Freudenreich M.D.

引用次数: 0

Applying (or Not?) CAR-T Neurotoxicity Experience to COVID-19 Delirium and Agitation 申请(或不申请?)CAR-T治疗COVID-19谵妄和躁动的神经毒性体会

IF 3.4 Q2 Medicine

Psychosomatics

Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.04.018

Avram H. Mack M.D., Hannah-Lise Schofield Ph.D.

引用次数: 2

Psychiatric Symptoms in Pediatric Patients With Myelin-Oligodendrocyte-Glycoprotein-Immunoglobulin G-Antibody Positive Autoimmune Encephalitis: A Case Series 髓磷脂-少突胶质细胞-糖蛋白-免疫球蛋白g抗体阳性自身免疫性脑炎患儿的精神症状:一个病例系列

IF 3.4 Q2 Medicine

Psychosomatics

Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2019.12.002

James H. Powers B.S. , GenaLynne C. Mooneyham M.D., M.S.

引用次数: 3

Acute Bipolar Psychosis Limited to the Course of an Ectopic Pregnancy 急性双相精神病局限于异位妊娠的过程

IF 3.4 Q2 Medicine

Psychosomatics

Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.03.009

Sarah A. Reinstein M.D. , Kristina M. Deligiannidis M.D.

引用次数: 1

Neuropsychiatric Symptoms in an Adolescent Boy With Multisystem Inflammatory Syndrome in Children 儿童多系统炎症综合征青春期男孩的神经精神症状

IF 3.4 Q2 Medicine

Psychosomatics

Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.06.015

Lisa Hutchison M.D. , Anna M. Plichta M.D. , Yehuda Lerea M.D. , Marlee Madora M.D. , H. Michael Ushay M.D., Ph.D.

引用次数: 20

Intravenous Misuse of Unsterilized Methamphetamine Bong Water Laced With Vape Juice 未经消毒的甲基苯丙胺水掺有电子烟的静脉注射误用

IF 3.4 Q2 Medicine

Psychosomatics

Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.07.001

Jonathan S. Constant D.O., Sheryl B. Fleisch M.D.

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Psychosomatics

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀